Involvement of Heme Oxygenase-1 in Neuropsychiatric and Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|24|20|2283-2302

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.24, Iss.20, 2018-06, pp. : 2283-2302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases

By  

Current Drug Targets, Vol. 11, Iss. 12, 2010-12 ,pp. : 1517-1531

Bentham Science Publishers

Access to resources Recommend Favorite

Heme Oxygenase-1 as a Therapeutic Target in Neurodegenerative Diseases and Brain Infections

By  

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 429-442

Bentham Science Publishers

Access to resources Recommend Favorite

Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases

By  

Current Gene Therapy, Vol. 14, Iss. 3, 2014-06 ,pp. : 218-235

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Statins in the Activation of Heme Oxygenase-1 in Cardiovascular Diseases

By  

Current Drug Targets, Vol. 18, Iss. 6, 2017-03 ,pp. : 674-686

Bentham Science Publishers

Access to resources Recommend Favorite

Inducers of Heme Oxygenase-1

By  

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 473-486

Bentham Science Publishers

Access to resources Recommend Favorite